Gilead Sciences Inc. (GILD) Gilead Sciences to Acquire Immunomedics Conference Call (Transcript)Seeking Alpha • 09/15/20
Monoclonal Antibodies: A Good Place To Be In The Time Of Covid-19 And Stock Market BubblesSeeking Alpha • 09/15/20
Gilead’s Magrolimab, an Investigational Anti-CD47 Monoclonal Antibody, Receives FDA Breakthrough Therapy Designation for Treatment of Myelodysplastic SyndromeBusiness Wire • 09/15/20
Jefferies Top Growth Stocks to Buy Include 4 Red-Hot Health Care Companies24/7 Wall Street • 09/15/20
Gilead Makes Its Biggest Buy Ever And Gets A 'Flagship' Cancer DrugInvestors Business Daily • 09/14/20